Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection. - PubMed - NCBI

N Engl J Med. 2017 Jan 26;376(4):305-317. doi: 10.1056/NEJMoa1602615. Clinical Trial, Phase III; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't